Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Dermatol ; 46(9): 812-815, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31271447

ABSTRACT

A 3-month-old boy developed small papules on his trunk. After the papules increased in number, the patient was diagnosed with Langerhans cell histiocytosis based on the pathological findings. He was referred to our department for further examination. Upon initial examination, the papules and nodules were scattered on his back, abdomen and lumbar region. Because he did not present with any organ involvement except the skin, he was diagnosed with single-system and skin-limited Langerhans cell histiocytosis. Skin rashes were treated with a topical steroid and started regressing 3 months after onset. All papules disappeared 6 months after onset. In this boy, the Langerhans cell histiocytosis tumor cells expressed phosphorylated extracellular signal-regulated kinases. In Langerhans cell histiocytosis, BRAF V600E and other genes are known to mutate to act as driver mutations in stem cells of the myeloid dendritic cell lineage. Consequently, extracellular signal-regulated kinases are continuously activated, which contributes to Langerhans cell histiocytosis carcinogenesis.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/immunology , Histiocytosis, Langerhans-Cell/immunology , Neoplasm Regression, Spontaneous/immunology , Skin Neoplasms/immunology , Administration, Cutaneous , Biopsy , Extracellular Signal-Regulated MAP Kinases/metabolism , Glucocorticoids/administration & dosage , Histiocytosis, Langerhans-Cell/congenital , Histiocytosis, Langerhans-Cell/drug therapy , Histiocytosis, Langerhans-Cell/pathology , Humans , Infant , Langerhans Cells/immunology , Langerhans Cells/pathology , Male , Phosphorylation/immunology , Skin/cytology , Skin/immunology , Skin/pathology , Skin Neoplasms/drug therapy , Skin Neoplasms/pathology
3.
J Infect Dis ; 216(7): 850-858, 2017 10 17.
Article in English | MEDLINE | ID: mdl-28968717

ABSTRACT

Background: Non-acquired immune deficiency syndrome (AIDS) Kaposi's sarcoma (KS) is extremely rare in Japan but highly endemic in Okinawa, especially in Miyako Islands. We aimed to elucidate the exact incidence and cause of this high prevalence. Methods: Non-AIDS KS cases in Okinawa Prefecture over the past 31 years were reviewed, and human herpesvirus 8 (HHV8) seroprevalence in Miyako Islands was determined. We examined whole-genome sequences of 3 HHV8 strains and performed whole-exome sequencing of 4 male patients from Miyako Islands. Results: Approximately half of the non-AIDS KS cases in Okinawa Prefecture were from Miyako Islands. The age-adjusted incidence rate was 0.87/105 per year for Miyako Islands and 0.056/105 per year for the rest of Okinawa. Human herpesvirus 8 seroprevalence was 15.4% in Miyako Islands. The 3 HHV8 genomes isolated from Miyako islanders formed a phylogenetically branch distinct from those of previously sequenced HHV8 strains and shared specific mutations in 9 proteins. These mutations were verified in Okinawan patients other than those from Miyako Islands. Whole-exome sequencing of the 4 male Miyako Islanders did not reveal shared pathogenic mutations. Conclusions: Miyako Islands are an endemic area of non-AIDS KS. The high rate of a distinct HHV8 may contribute to the high incidence of KS in the region.


Subject(s)
Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/virology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Genome, Viral , Humans , Islands/epidemiology , Japan/epidemiology , Male , Middle Aged , Sarcoma, Kaposi/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...